Quattro Financial Advisors’s Gilead Sciences GILD Stock Holding History

Quattro Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$385K	–	86
2023 Q2	$385K	Sell	5,000 -5,000	-50%	-$399K	0.15%	65
2023 Q1	$830K	Hold	10,000	–	–	0.34%	52
2022 Q4	$859K	Hold	10,000	–	–	0.34%	47
2022 Q3	$617K	Hold	10,000	–	–	0.25%	56
2022 Q2	$618K	Hold	10,000	–	–	0.21%	55
2022 Q1	$595K	Hold	10,000	–	–	0.2%	59
2021 Q4	$726K	Hold	10,000	–	–	0.26%	64
2021 Q3	$673K	Hold	10,000	–	–	0.18%	69
2021 Q2	$689K	Hold	10,000	–	–	0.18%	72
2021 Q1	$659K	Buy	+10,000	New	+$645K	0.15%	76

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quattro Financial Advisors's GILD Position: Q3 2023 in Review

Quattro Financial Advisors sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 5,000 shares — an estimated $385K sold.

Quattro Financial Advisors first reported a position in GILD in Q1 2021 and held it in 10 quarters. The position peaked at $859K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Quattro Financial Advisors reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Quattro Financial Advisors sold 5,000 Gilead Sciences shares in Q3 2023, an estimated $385K.
Quattro Financial Advisors first reported a position in Gilead Sciences in Q1 2021 and held it in 10 quarters.
Quattro Financial Advisors's Gilead Sciences position peaked at $859K in Q4 2022.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Quattro Financial Advisors's 13F filing for Q3 2023, filed 20 Oct 2023.